June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Yan Leyfman: Are Immune Checkpoint Inhibitors Safe for Patients with Neurologic Autoimmune Disorders?
Jun 9, 2025, 07:12

Yan Leyfman: Are Immune Checkpoint Inhibitors Safe for Patients with Neurologic Autoimmune Disorders?

Yan Leyfman, Co-founder and Executive Director of MedNews Week, posted on X:

“Are Immune Checkpoint Inhibitors (ICIs) Safe for Patients with Neurologic Autoimmune Disorders (NAIDs)?

A multicenter study of 135 cancer patients with NAIDs sheds light:

  • Myasthenia Gravis (MG): Highest risk — 67% had neurologic exacerbations, some severe or fatal.
  • Multiple Sclerosis (MS): 18% experienced flares — generally milder.
  • Guillain-Barré (GBS): No exacerbations observed, but 1 fatal immune-related event.
  • Survival Outcomes: No difference in PFS or OS across NAID groups.

Takeaway: ICIs may be viable for many with NAIDs, but caution is crucial, especially in MG.”

Title: Immune Checkpoint Inhibitors for Patients With Preexisting Autoimmune Neurologic Disorders

Authors: Kylie Fletcher, Marc Machaalani, Razane El Hajj Chehade, Amin H. Nassar, Rashad Nawfal, Michael Manos, Alexander M. Menzies, Frank Aboubakar-Nana, Jessica C. Hassel, David J. Pinato, Alexandra Johnson, Anna C. Olsson-Brown, Matteo S. Carlino, Andrea Malgeri, Alessio Cortellini, Aditi Singh, Kaushal Parikh, So Yeon Kim, Abdul Rafeh Naqash, Georgina V. Long, Pavan Challa, Toni K. Choueiri, Elad Sharon, Shailee Shah, Douglas B. Johnson

Read The Full Article at JAMA Network.

Yan Leyfman: Are Immune Checkpoint Inhibitors Safe for Patients with Neurologic Autoimmune Disorders?

More posts featuring Yan Leyfman on OncoDaily.